Effect of Lymphocyte miRNA Expression on Influenza Vaccine-Induced Immunity

Iana Haralambieva,Tamar Ratishvili,Krista Goergen,Diane Grill,Whitney Simon,Jun Chen,Inna G Ovsyannikova,Gregory A. Poland,Rick G Kennedy
DOI: https://doi.org/10.1101/2024.11.02.24316654
2024-11-04
Abstract:Alterations of gene expression by miRNAs contribute substantially to genetic regulation and cellular functions. We conducted a comprehensive study in 53 individuals before and after the administration of the 2010-2011 seasonal inactivated influenza vaccine to characterize lymphocyte-specific miRNA expression (in purified B cells, CD4+ T cells, CD8+ T cells and NK cells) and its effect on influenza vaccine-induced immune outcomes (hemagglutination inhibition antibody titers/HAI, viral neutralizing antibody titers /VNA and memory B cell ELISPOT). Overall, we observed relatively stable miRNA expression before/after influenza vaccination. Our statistical analysis uncovered three baseline miRNAs (miR-150-3p, miR-629-5p and miR-4443) that were significantly correlated with influenza vaccine-induced immune outcomes in different cell types. Predictive modeling of influenza vaccine-induced HAI/VNA titers identified a set of specific baseline miRNAs in CD4+ T cells as factors predictive of antibody responses. A pathway enrichment analysis on the putative target genes revealed several regulated signaling pathways and functions: TGF-β signaling, PI3K-Akt signaling, p53 signaling, MAPK signaling, TNF signaling and C-type lectin receptor signaling, as well as cell adhesion and adherens junctions, and antiviral host response.
Allergy and Immunology
What problem does this paper attempt to address?